Compare Heron Therapeutics Inc (HRTX) vs Trade Desk Inc (TTD) Price & Performance

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

The Trade Desk (TTD) trades at $18.68, down 76% year-to-date amid slowing revenue growth and executive turnover. Recent technical signals are bearish, with moving averages indicating selling pressure, while fundamentals show strong profitability with a 77.83% gross margin and 14.57% net margin. The company has beaten earnings estimates in two of the last three quarters but missed Q1 2026 expectations. Recent news highlights key executive appointments and a resolved dispute with Publicis Groupe.

Outlook: TTD faces headwinds from competitive pressure and growth deceleration, but current valuation at 21.13x P/E may attract value investors. Risks include market share loss to larger rivals and execution challenges. Analyst consensus price target of $25.23 suggests 35% upside potential, though sentiment remains divided with nearly equal buy and hold ratings.